Combining biological markers to estimate the realized niche species : the case of three flatfish in Seine estuary

Autor: BRIND’AMOUR , A., DUBÉ , B., LAGHZALI , Y., DURIEUX , E., Mahé , K., Dauvin , Jean-Claude, Alizier , S., TOUS , RIUS, A. LE , HIR, MORIN. , J.

Publikováno v: Forum TransChannel ‘Science and Governance of the Channel Marine Ecosystem
Forum TransChannel ‘Science and Governance of the Channel Marine Ecosystem, Jul 2014, caen, France
Forum TransChannel ‘Science and Governance of the Channel Marine Ecosystem, Jul 2014, Caen, France

International audience

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::24d26e2ec436177de0c62c5bf5b3f94e
https://hal.archives-ouvertes.fr/hal-01708593

Évaluation de l’impact thérapeutique de la TEP/TDM à la 18F-Choline dans la prise en charge des cancers de la prostate

Autor: Delfort, F., Deshayes, E., Eberle-Pouzeratte, M.C., Guillemard, S., Fontaine, M., Laghzali, Y., Azria, D., Kotzki, P.O.

Publikováno v: In Medecine Nucleaire May 2015 39(3):255-255

Guip1 : une interface graphique pour la planification des essais cliniques de phase I

Autor: Fraisse, J., Dinart, D., Tosi, D., Mauguen, A., Laghzali, Y., Touraine, C., Le Deley, M.-C., Bellera, C., Mollevi, C.

Publikováno v: Revue d Epidemiologie et de Sante Publique; May 2018, Vol. 66 Issue: 1, Number 1 Supplement 3 pS176-S177, 2p

Impact de la définition des critères de survie sur les résultats des essais cliniques randomisés en cancérologie (DATECAN-2) : premiers résultats

Autor: Laghzali, Y., Savina, M., Pam, A., Vernerey, D., Bellera, C., Gourgou-Bourgade, S., Mathoulin-Pélissier, S., Bonnetain, F.

Publikováno v: Revue d Epidemiologie et de Sante Publique; August 2014, Vol. 62 Issue: 1, Number 1 Supplement 4 pS117-S117, 1p

Serum Matrix Metalloproteinase-7 is an independent prognostic biomarker in advanced bladder cancer.

Autor: El Demery M; Department of Medical Oncology, Cap d¿Or Clinic, La Seyne sur Mer, France., Demirdjian-Sarkissian G; Clinical Diagnostic Division, Thermo Fisher Scientific, Nimes, France., Thezenas S; Department of Biostatistics, Institut Régional du Cancer de Montpellier (ICM), Val d¿Aurelle, Montpellier, France., Jacot W; Department of Medical Oncology, Institut Régional du Cancer de Montpellier (ICM), Val d¿Aurelle, Montpellier, France., Laghzali Y; Department of Biostatistics, Institut Régional du Cancer de Montpellier (ICM), Val d¿Aurelle, Montpellier, France., Darbouret B; Clinical Diagnostic Division, Thermo Fisher Scientific, Nimes, France., Culine S; Hôpital Saint-Louis, APHP, Saint-Louis, France., Rebillard X; Clinique Beausoleil, Montpellier, France., Lamy PJ; Department of Biology and Oncogenetics, Institut Régional du Cancer de Montpellier (ICM), Val d¿Aurelle, Montpellier, 34298, France.

Publikováno v: Clinical and translational medicine [Clin Transl Med] 2014 Oct 28; Vol. 3, pp. 31. Date of Electronic Publication: 2014 Oct 28 (Print Publication: 2014).